BIBW 2992 as add-on to Gem/Cis in Advanced Biliary Tract Cancer
Status:
Terminated
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
An open-label, uncontrolled, multicenter phase I/Ib trial to investigate safety and efficacy
of BIBW 2992 added to the standard therapy of Gemcitabine/Cisplatin in chemo-naïve patients
with advanced and/or metastatic adenocarcinoma of the biliary tract